ArticleJournal of bacteriology2011
Complete genome sequence of the probiotic strain Lactobacillus casei BD-II.
Article in Journal of bacteriology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Comparative genomic analysis ofFrontiers in microbiology · 2022Article
- NADH peroxidase plays a crucial role in consuming HBioscience of microbiota, food and health · 2020Article
- Comparative Genomics ofFrontiers in microbiology · 2019Article
- Complete genome sequence ofGut pathogens · 2018Article
- Article
- The impact of heterologous catalase expression and superoxide dismutase overexpression on enhancing the oxidative resistance in Lactobacillus casei.Journal of industrial microbiology & biotechnology · 2016Article
- Complete Genome Sequence of the Probiotic Strain Lactobacillus casei (Formerly Lactobacillus paracasei) LOCK919.Genome announcements · 2013Article
- Comparative genome analysis of Lactobacillus casei strains isolated from Actimel and Yakult products reveals marked similarities and points to a common origin.Microbial biotechnology · 2013Article
- Utilization of D-ribitol by Lactobacillus casei BL23 requires a mannose-type phosphotransferase system and three catabolic enzymes.Journal of bacteriology · 2013Article
- Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics.Applied and environmental microbiology · 2013Article
- Genomic adaptation of the Lactobacillus casei group.PloS one · 2013Article
- Lactobacillus paracasei comparative genomics: towards species pan-genome definition and exploitation of diversity.PloS one · 2013Article
- Draft genome sequence of Lactobacillus casei W56.Journal of bacteriology · 2012Article
- Analysis of the Lactobacillus casei supragenome and its influence in species evolution and lifestyle adaptation.BMC genomics · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lactobacillus casei BD-II, a patented probiotic strain (U.S. patent 7,270,994 B2), was isolated from homemade koumiss in China and has been implemented in the industrial production as starter cultures. Here we report the complete genome sequence of BD-II, which shows high similarity with the well-studied probiotic BL23.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.